SMITHTOWN, NY, April 7, 2017 Marketwired -- iGambit Inc. (OTCQB: IGMB), announced that on April 6, 2017 it acquired the CyberCare Health Network Division from EncounterCare Solutions Inc. (ECSL). Under the terms of the agreement iGambit, bought certain assets of EncounterCare. Payment was made in the form of IGMB stock.
CyberCare will operate as a division of the recently acquired HubCentrix Company, whose new name is HealthDatix, Inc.
A copy of the Form 8-K report may be accessed at www.sec.gov.
The acquisition of HubCentrix and the CyberCare Health Network Chronic Care Management System provides a new and unique opportunity for physicians to identify patients eligible for both “Annual Wellness Visits” as well as “Chronic Care Management” both of which are reimbursed by Medicare.
The goal of HealthDatix will be to identify the patient’s eligibility for Medicare reimbursed doctor visits to access and assist in the well-being and cultivation of a healthy lifestyle. Additionally HealthDatix is able to provide an FDA approved, Medicare covered platform, for continuous management of chronic care patients. Our continuous care platform will be tailored for individual care and health management of patients susceptible to chronic illness.
The HealthDatix platform is designed to accumulate information from any TeleMedicine or wearable device. This includes CyberCare’s own wearable medical watch, a wearable device under development, that will continuously collect and trend data.
Key Health Parameters:
• Heart Rate
• Blood Pressure
• SPO2 (Oxygenation of blood)
• Key Cardiac Function (“Mini-ECG”)
Different than other devices on the market:
• Patented Instrumentation
• Medically accurate
• Designed to provide data directly to a health care provider through HealthDatix solution,
• Share real-time information with health care providers and family
• Provides better, and earlier, identification of patient health issues and treatment compliance
The completed wearable, when paired with the CyberCare Health Network Chronic Care Management System, will become part of the FDA approved chronic care management system.
John Salerno, Chairman of iGambit, “As I previously stated we are very pleased to have this new business opportunity which we believe will increase our stockholders value. Our management team and advisors are very accomplished at introducing and administering rapid growth technology services. We anticipate that our exciting newly combined entity HealthDatix, will have the professionals in place to competently deal with the accelerated growth curve necessary to meet the needs of physician community throughout the country.”
Ronald Mills Sr., CEO of EncounterCare stated, “I am very pleased that we have been able to successfully complete this deal with HealthDatix and iGambit. The HealthDatix management team led by Jerry Robinson, President, has put together a very exciting program that I believe will benefit the medical community and which, I also believe will bring significant value to EncounterCare and our stockholders.”
About iGambit Inc: iGambit (OTCBB: IGMB) is a fully reporting publicly-held company. We are a company focused on pursuing specific medical strategies and objectives. These objectives have included, among others, the acquisition of medical technology companies with strong growth potential easily recognized in the public arena. We believe that the back-ground of our management and of our Board of Directors in the technology markets is a valuable resource that makes us a desirable business partner. We expect to work to assume an active role in the development and growth of the new company, providing both strategic guidance and operational support. The management of iGambit believes that it can leverage its collective expertise to help position the combined company to produce high-margin, recurring and predictable earnings and generate long-term value for our stockholders. For more information, please visit www.igambit.com. Information on our web-site does not comprise a part of this press release.
Cautionary Note Regarding Forward-Looking Statements
Certain statements in this document and elsewhere by iGambit are ‘forward-looking statements’ within the meaning of the Private Securities Litigation Reform Act of 1995. Such information includes, without limitation, the business outlook, assessment of market conditions, anticipated financial and operating results, strategies, future plans, contingencies and contemplated transactions of the company. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and other factors which may cause or contribute to actual results of company operations, or the performance or achievements of the company or industry results, to differ materially from those expressed, or implied by the forward-looking statements. In addition to any such risks, uncertainties and other factors discussed elsewhere herein, risks, uncertainties and other factors that could cause or contribute to actual results differing materially from those expressed or implied for the forward- looking statements include, but are not limited to fluctuations in demand; changes to economic growth in the U.S. and U.S. government policies and regulations, including, but not limited to those affecting the medical fertility clinic industry. iGambit undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Actual results, performance or achievements could differ materially from those anticipated in such forward-looking statements as a result of certain factors, including those set forth in iGambit Inc.'s filings with the Securities and Exchange Commission.